Becton Dickinson & Company Bard 3F SL PowerMidline Basic Kit CE-indicated for short term access to the peripheral venous system for selected intravenous therapies, blood sampling, and power injection of contrast media Ref: P6153118 Recall
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Bard 3F SL PowerMidline Basic Kit CE-indicated for short term access to the peripheral venous system for selected intravenous therapies, blood sampling, and power injection of contrast media Ref: P6153118
Brand
Becton Dickinson & Company
Lot Codes / Batch Numbers
Lot Number: REEP2920 Exp. Date: Jan-2022 UDI: 00801741141027
Products Sold
Lot Number: REEP2920 Exp. Date: Jan-2022 UDI: 00801741141027
Becton Dickinson & Company is recalling Bard 3F SL PowerMidline Basic Kit CE-indicated for short term access to the peripheral venous system due to Kits do not contain the stylet/T-lock assembly indicated as a component on the label, may lead to a procedural delay and possibly discard of the kit.. Based on FDA medical device recall database.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Kits do not contain the stylet/T-lock assembly indicated as a component on the label, may lead to a procedural delay and possibly discard of the kit.
Recommended Action
Per FDA guidance
Becton Dickinson (BD) issued notification letter to FSN Europe on 9/14/20 to customer stating reason for recall, health risk and action to take specific to the country: Advice on actions to be taken by the Distributor: 1. Inspect your inventory, locate and quarantine any units of the impacted devices listed in Table 1. 2. If you have further distributed the product, please identify those facilities, notify them at once of this product removal and have them return the affected product to your facility. 3. Destroy any unused units of the affected product and complete the customer response form on page 3 indicating: o the quantities destroyed OR o that your organisation does not have any impacted units left in inventory 4. Return the completed Customer Response Form to <> as soon as possible or no later than October 9th, 2020. Should you have any questions or require assistance relating to this Field Safety Notice, please contact your Local BD representative at <>
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 10, 2026